ArticleOncoimmunology2021
PD-L2 based immune signature confers poor prognosis in HNSCC.
Yu Qiao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
this paperpooled itcites it
ArticleOncoimmunology2021
Yu Qiao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.